ADAMTS4
A disintegrin and metalloproteinase with thrombospondin motifs 4
Also known as: ADAMTS-2, ADMP-1, ATS4_HUMAN, KIAA0688
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75173
- Gene
- ADAMTS4
- Ensembl
- ENSG00000158859
- Chromosome
- 1
- Canonical length
- 837 aa
- Protein class
- Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters
- Subcellular location
- Nuclear speckles
- Secretome location
- Secreted to extracellular matrix
OverviewNCBI Gene
This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of this family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The enzyme encoded by this gene lacks a C-terminal TS motif. The encoded preproprotein is proteolytically processed to generate the mature protease. This protease is responsible for the degradation of aggrecan, a major proteoglycan of cartilage, and brevican, a brain-specific extracellular matrix protein. The expression of this gene is upregulated in arthritic disease and this may contribute to disease progression through the degradation of aggrecan. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]
Canonical amino-acid sequenceUniProt
837 residues, UniProt reviewed canonical sequence.
>O75173|ADAMTS4
1 MSQTGSHPGR GLAGRWLWGA QPCLLLPIVP LSWLVWLLLL LLASLLPSAR LASPLPREEE
61 IVFPEKLNGS VLPGSGAPAR LLCRLQAFGE TLLLELEQDS GVQVEGLTVQ YLGQAPELLG
121 GAEPGTYLTG TINGDPESVA SLHWDGGALL GVLQYRGAEL HLQPLEGGTP NSAGGPGAHI
181 LRRKSPASGQ GPMCNVKAPL GSPSPRPRRA KRFASLSRFV ETLVVADDKM AAFHGAGLKR
241 YLLTVMAAAA KAFKHPSIRN PVSLVVTRLV ILGSGEEGPQ VGPSAAQTLR SFCAWQRGLN
301 TPEDSDPDHF DTAILFTRQD LCGVSTCDTL GMADVGTVCD PARSCAIVED DGLQSAFTAA
361 HELGHVFNML HDNSKPCISL NGPLSTSRHV MAPVMAHVDP EEPWSPCSAR FITDFLDNGY
421 GHCLLDKPEA PLHLPVTFPG KDYDADRQCQ LTFGPDSRHC PQLPPPCAAL WCSGHLNGHA
481 MCQTKHSPWA DGTPCGPAQA CMGGRCLHMD QLQDFNIPQA GGWGPWGPWG DCSRTCGGGV
541 QFSSRDCTRP VPRNGGKYCE GRRTRFRSCN TEDCPTGSAL TFREEQCAAY NHRTDLFKSF
601 PGPMDWVPRY TGVAPQDQCK LTCQAQALGY YYVLEPRVVD GTPCSPDSSS VCVQGRCIHA
661 GCDRIIGSKK KFDKCMVCGG DGSGCSKQSG SFRKFRYGYN NVVTIPAGAT HILVRQQGNP
721 GHRSIYLALK LPDGSYALNG EYTLMPSPTD VVLPGAVSLR YSGATAASET LSGHGPLAQP
781 LTLQVLVAGN PQDTRLRYSF FVPRPTPSTP RPTPQDWLHR RAQILEILRR RPWAGRKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADAMTS4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 109 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 109 nTPM
- ovary: 85 nTPM
- heart muscle: 51 nTPM
- lung: 47 nTPM
- breast: 41 nTPM
- blood vessel: 38 nTPM
Single-cell type
- pericytes: 498 nCPM
- vascular smooth muscle cells: 276 nCPM
- smooth muscle cells: 152 nCPM
- vascular endothelial cells: 151 nCPM
- fibroblasts: 97 nCPM
- ovarian stromal cells: 86 nCPM
Immune cell
- plasmacytoid DC: 4.4 nTPM
- basophil: 0.4 nTPM
- neutrophil: 0.4 nTPM
- gdT-cell: 0.2 nTPM
- classical monocyte: 0.1 nTPM
- eosinophil: 0.1 nTPM
Brain region
- white matter: 112 nTPM
- medulla oblongata: 93 nTPM
- cerebellum: 77 nTPM
- basal ganglia: 76 nTPM
- pons: 74 nTPM
- midbrain: 73 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.71
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.15
- DepMap mean gene effect
- -0.16
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- defense response to bacterium
- extracellular matrix disassembly
- extracellular matrix organization
- proteoglycan catabolic process
- proteolysis
- skeletal system development
Molecular functions
- metalloendopeptidase activity
- metallopeptidase activity
- peptidase activity
- protease binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Thrombospondin type-1 (TSP1) repeat
- Peptidase M12B, ADAM/reprolysin
- ADAM, cysteine-rich domain
- ADAMTS/ADAMTS-like, Spacer 1
- ADAMTS/ADAMTS-like
- Metallopeptidase, catalytic domain superfamily
- Thrombospondin type-1 repeat superfamily
- ADAMTS, cysteine-rich domain 2
- ADAMTS/ADAMTS-like, cysteine-rich domain 3
- ADAMTS and ADAMTS-like
- Thrombospondin type 1 domain
- Reprolysin (M12B) family zinc metalloprotease
- ADAM-TS Spacer 1
- ADAMTS cysteine-rich domain 2
- ADAMTS cysteine-rich domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADAMTS4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADAMTS4 as an antibody target. Whether an autoantibody or antibody against ADAMTS4 could matter depends on whether native ADAMTS4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADAMTS4 is annotated as secreted, so native ADAMTS4 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label ADAMTS4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...